The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience

[1]  Sang Nam Lee,et al.  Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[2]  Joe Y. Chang,et al.  Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  Kenji Suzuki,et al.  Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. , 2014, The Journal of thoracic and cardiovascular surgery.

[4]  Y. Korogi,et al.  Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. , 2013, Lung cancer.

[5]  J. Slater,et al.  High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center. , 2013, International journal of radiation oncology, biology, physics.

[6]  W. Nishio,et al.  A case of acute exacerbation of idiopathic pulmonary fibrosis after proton beam therapy for non-small cell lung cancer. , 2012, Japanese journal of clinical oncology.

[7]  Mitsuhiro Nakamura,et al.  Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[8]  N. Saijo,et al.  Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). , 2012, The Lancet. Oncology.

[9]  Joe Y. Chang,et al.  Phase 2 study of high‐dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer , 2011, Cancer.

[10]  M. Murasugi,et al.  Acute exacerbation of idiopathic interstitial pneumonias after surgical resection of lung cancer. , 2011, Interactive cardiovascular and thoracic surgery.

[11]  H. Collard,et al.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[12]  Takuya Tomoda,et al.  Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer. , 2010, International journal of radiation oncology, biology, physics.

[13]  Masaaki Kawahara,et al.  Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  K. Ohtomo,et al.  Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy , 2010, Radiation oncology.

[15]  R. Barriger,et al.  A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. , 2009, International journal of radiation oncology, biology, physics.

[16]  E. Kunieda,et al.  Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing , 2008, Radiation Medicine.

[17]  K. Ohtomo,et al.  Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors , 2007, Radiation oncology.

[18]  K. Nihei,et al.  High-dose proton beam therapy for Stage I non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[19]  I. Mikami,et al.  Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. , 2004, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[20]  Harald Paganetti,et al.  Proton Beams to Replace Photon Beams in Radical Dose Treatments , 2003, Acta oncologica.

[21]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[22]  S. Webb,et al.  Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). , 1999, The British journal of radiology.

[23]  P. Hugh-Jones.  Simple Standard Exercise Test for Measuring Exertion Dyspnoea , 1952, British medical journal.

[24]  S. Rosselot.  Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[25]  R. Hubbard,et al.  Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. , 2000, American journal of respiratory and critical care medicine.